Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices ( EILAT XIII )-Reference-Cited by-同舟云学术

Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices ( EILAT XIII )

Published:2017-01-23 Issue:2 Volume:58 Page:181-221
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Bialer Meir¹,Johannessen Svein I.²³,Levy René H.⁴,Perucca Emilio⁵⁶,Tomson Torbjörn⁷,White H. Steve⁸

Affiliation:

1. Faculty of Medicine School of Pharmacy and David R. Bloom Center for Pharmacy Institute for Drug Research The Hebrew University of Jerusalem Jerusalem Israel

2. The National Center for Epilepsy Sandvika Norway

3. Department of Pharmacology Oslo University Hospital Oslo Norway

4. Department of Pharmaceutics and Neurological Surgery University of Washington Seattle Washington U.S.A.

5. Department of Internal Medicine and Therapeutics University of Pavia Pavia Italy

6. C. Mondino National Neurological Institute Pavia Italy

7. Department of Clinical Neuroscience Karolinska Institute Stockholm Sweden

8. Department of Pharmacy School of Pharmacy University of Washington Seattle Washington U.S.A.

Funder

Deutsche Forschungsgemeinschaft

Ministry of Defense

Agenzia Italiana del Farmaco, Ministero della Salute

Stockholms Läns Landsting

Citizens United for Research in Epilepsy

GlaxoSmithKline

Novartis

Eisai

U.S. Department of Defense

National Institutes of Health

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/epi.13634

Reference189 articles.

1. Progress report on new antiepileptic drugs: A summary of the Tenth Eilat Conference (EILAT X)

2. Progress report on new antiepileptic drugs: A summary of the Eleventh Eilat Conference (EILAT XI)

3. Progress report on new antiepileptic drugs: A summary of the Twelfth Eilat Conference (EILAT XII)

4. Adenosinergic signaling in epilepsy

5. Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically based pharmacokinetic model of brivaracetam to predict the exposure and dose exploration in hepatic impairment and elderly populations;Journal of Pharmaceutical Sciences;2024-09

2. A profile of azetukalner for the treatment of epilepsy: from pharmacology to potential for therapy;Expert Review of Clinical Pharmacology;2024-04-03

3. Current pharmacotherapy approaches and novel GABAergic antidepressant development in postpartum depression;Dialogues in Clinical Neuroscience;2023-10-05

4. Modulators of GABAA receptor-mediated inhibition in the treatment of neuropsychiatric disorders: past, present, and future;Neuropsychopharmacology;2023-09-14

5. Treating Epilepsy with Natural Products: Nonsense or Possibility?;Pharmaceuticals;2023-07-26